XML 63 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Jan. 01, 2023
Income Tax Disclosure [Abstract]  
Provision for Income Taxes The provision for taxes on income consists of:
(Dollars in Millions)202220212020
Currently payable:
U.S. taxes$2,378 1,525 1,026 
International taxes3,069 2,452 1,898 
Total currently payable5,447 3,977 2,924 
Deferred:
U.S. taxes(2,081)583 (76)
International taxes418 (2,662)(1,065)
Total deferred(1,663)(2,079)(1,141)
Provision for taxes on income$3,784 1,898 1,783 
Comparison of Income Taxes at Statutory Rate and Company's Effective Tax Rate
A comparison of income tax expense at the U.S. statutory rate of 21% in fiscal years 2022, 2021 and 2020, to the Company’s effective tax rate is as follows:
(Dollars in Millions)202220212020
U.S. $5,369 6,110 4,312 
International16,356 16,666 12,185 
Earnings before taxes on income:$21,725 22,776 16,497 
Tax rates:
U.S. statutory rate21.0 %21.0 21.0 
International operations (1)
(4.5)(16.4)(9.9)
Consumer health separation2.2 — — 
U.S. taxes on international income (2)
(1.9)6.7 2.7 
Tax benefits from loss on capital assets— (1.3)(1.2)
Tax benefits on share-based compensation(1.3)(1.0)(1.5)
All other (3)
1.9 (0.7)(0.3)
Effective Rate17.4 %8.3 10.8 

(1) For all periods presented the Company has subsidiaries operating in Puerto Rico under various tax incentives. International operations reflect the impacts of operations in jurisdictions with statutory tax rates different than the U.S., particularly Ireland, Switzerland and Puerto Rico, which is a favorable impact on the effective tax rate as compared with the U.S. statutory rate. The 2021 amounts include the reorganization of international subsidiaries; the 2020 amounts include the impact of the new tax legislation enactment in Switzerland, both of which are further described below.
(2) Includes the impact of the GILTI tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. The 2022 amount includes the impact of certain provisions of the 2017 TCJA that became effective in fiscal 2022. The 2021 amounts include the reorganization of international subsidiaries; the 2020 amounts include the impact of the new tax legislation enactment in Switzerland, both of which are further described below.
(3) Certain prior year amounts have been reclassified to conform to current year presentation.
Temporary Differences and Carryforwards
Temporary differences and carryforwards at the end of fiscal years 2022 and 2021 were as follows:
2022 Deferred Tax
2021 Deferred Tax(1)
(Dollars in Millions)AssetLiabilityAssetLiability
Employee related obligations$725 1,244 
Stock based compensation687 679 
Depreciation of property, plant and equipment(858)(876)
Goodwill and intangibles(4,271)
(3)
(2,659)
(2)
R&D capitalized for tax2,611 1,664 
Reserves & liabilities2,761 2,882 
Income reported for tax purposes2,045 2,566 
Net realizable operating loss carryforwards(4)
1,260 1,720 
Undistributed foreign earnings1,565 (1,693)1,015 (1,461)
Global intangible low-taxed income(3,547)(4,853)
Miscellaneous international1,053 (65)870 (39)
Miscellaneous U.S. 476 (16)
Total deferred income taxes$13,183 (10,434)12,640 (9,904)
(1) Certain prior year amounts have been reclassified to conform to current year presentation.
(2) Amount is inclusive of the $2.3 billion deferred tax asset established as part of the reorganized ownership structure of certain wholly-owned international subsidiaries, as previously described.
(3) Amount is inclusive of the $1.8 billion deferred tax liability due to the acquisition of Abiomed.
(4) Net of valuation allowances of $0.9 billion in both 2022 and 2021.
Summary of Activity Related to Unrecognized Tax Benefits The following table summarizes the activity related to unrecognized tax benefits:
(Dollars in Millions)202220212020
Beginning of year$3,323 3,373 3,853 
Increases related to current year tax positions523 242 265 
Increases related to prior period tax positions143 23 668 
Decreases related to prior period tax positions(148)(128)(551)
Settlements(1)(187)(839)
Lapse of statute of limitations(11)— (23)
End of year$3,829 3,323 3,373